Skip to content
Disclosery

EXANE DERIVATIVES: DOC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DOC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13 DOC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13 shares
    Change vs previous 13F -94 shares

    <0.01% of the 13F portfolio, value $337.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 107 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $3,673.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 107 shares
    Change vs previous 13F -4,224 shares

    <0.01% of the 13F portfolio, value $3,862.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,331 shares
    Change vs previous 13F -5,800 shares

    0.04% of the 13F portfolio, value $145,008.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 10,131 shares
    Change vs previous 13F -1,964 shares

    0.08% of the 13F portfolio, value $349,325.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 12,095 shares
    Change vs previous 13F -1,092 shares

    0.12% of the 13F portfolio, value $383,913.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 13,187 shares
    Change vs previous 13F +3,729 shares

    0.12% of the 13F portfolio, value $398,661.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 9,458 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $256,792.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).